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Decreased expression of the Nlrp3 protein is associ-
atedwith susceptibility to Crohn’s disease. However,
the role of Nlrp3 in colitis has not been characterized.
Nlrp3 interacts with the adaptor protein ASC to acti-
vate caspase-1 in inflammasomes, which are protein
complexes responsible for thematuration and secre-
tion of interleukin-1b (IL-1b) and IL-18. Here, we
showed that mice deficient for Nlrp3 or ASC and cas-
pase-1 were highly susceptible to dextran sodium
sulfate (DSS)-induced colitis. Defective inflamma-
some activation led to loss of epithelial integrity,
resulting in systemic dispersion of commensal bac-
teria, massive leukocyte infiltration, and increased
chemokine production in the colon. This process
was a consequence of a decrease in IL-18 in mice
lacking components of the Nlrp3 inflammasome,
resulting in higher mortality rates. Thus, the Nlrp3
inflammasome is critically involved in the mainte-
nance of intestinal homeostasis and protection
against colitis.
INTRODUCTION
Human inflammatory bowel disease (IBD), comprising ulcerative
colitis and Crohn’s disease, constitutes a major health problem
in developed countries (Fiocchi, 1998). Ulcerative colitis exhibits
a characteristic profile of chronic inflammation involving the
distal colon and rectum and is generally recognized as an
immune-mediated disorder resulting from abnormal interaction
between colonic microflora and mucosal immune cells (Goyette
et al., 2007). Excessive inflammatory and immune responses in
the intestine are thought to be due to a breach in the epithelial
barrier in the gut that segregates commensal microflora from
the host’s systemic organs (Strober et al., 2002). Indeed, deteri-oration of the mucus layer of the colon is prominent in patients
with ulcerative colitis (Podolsky and Isselbacher, 1984; Rhodes,
1996). In addition, studies in rodents have linked tissue damage
and disruption of the epithelial barrier in the gut to cytokine
imbalances (Bouma and Strober, 2003). The production of these
inflammatory mediators has been implicated in the pathogenesis
of experimental colitis and IBD in humans (Podolsky, 2002).
The synthesis and secretion of proinflammatory cytokines is
governed by germline-encoded receptors such as the toll-like
receptor (TLR) and nucleotide-binding domain and leucine-
rich repeat containing (NLR) protein family (Kanneganti et al.,
2007; Kopp and Medzhitov, 2003). TLRs are membrane-bound
receptors that detect pathogen-associated molecular patterns
(PAMPs) in the extracellular milieu (Kawai and Akira, 2007).
TLR activation results in the rapid transcriptional activation of
effector genes, including cytokines and chemokines that drive
recruitment and/or activation of immune cells at mucosal sur-
faces. This immune cell recruitment is believed to play an impor-
tant role in protecting against bacterial dissemination but may
also underlie the clinical manifestations associated with inflam-
mation as well as tissue damage therein. For instance, mice lack-
ing the flagellin receptor TLR5 developed spontaneous colitis
(Vijay-Kumar et al., 2007). Although mice deficient for the lipo-
polysaccharide (LPS) receptor TLR4, the lipoprotein receptor
TLR2 or the TLR signaling adaptor MyD88 do not display an overt
intestinal phenotype, they develop exacerbated injury upon
exposure to dextran sodium sulfate (DSS) (Araki et al., 2005;
Fukata et al., 2005; Rakoff-Nahoum et al., 2004).
In addition to TLRs, several members of the cytosolic NLR
family have been identified as key regulators of cytokine produc-
tion (Kanneganti et al., 2007). Notably, the gene that encodes the
NLR protein CARD15 (also known as NOD2) was associated with
Crohn’s disease (Hugot et al., 2001; Ogura et al., 2001). NOD2
was subsequently shown to mediate activation of the transcrip-
tion factor NF-kB and MAP kinases (Girardin et al., 2003; Inohara
et al., 2003). The NLR protein Nlrp3 (also referred to as Nalp3,
CIAS1, or Cryopyrin) is involved in activation of the cysteine
protease caspase-1 (Lamkanfi et al., 2007). Homotypic interac-
tions between the pyrin domain in the N terminus of Nlrp3 andImmunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc. 379
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the association of caspase-1 to Nlrp3 in a large protein complex
referred to as the ‘‘inflammasome’’ (Martinon et al., 2002). Acti-
vated caspase-1 processes the cytosolic precursors of the
related cytokines interleukin-1b (IL-1b) and IL-18, thus allowing
secretion of the biologically active cytokines. Hence, mice lack-
ing caspase-1 are defective in the maturation and secretion of
IL-1b and IL-18 (Ghayur et al., 1997; Kuida et al., 1995;
Li et al., 1995). IL-1b participates in the generation of systemic
and local responses to infection, injury, and immunological chal-
lenges by generating fever, activating lymphocytes, and pro-
moting leukocyte infiltration at sites of injury or infection (Dinar-
ello, 1996). Although IL-18 lacks the pyrogenic activity of IL-1b,
it is involved in the induction of several secondary proinflamma-
tory cytokines, chemokines, cell adhesion molecules, and nitric
oxide synthesis (Horwood et al., 1998; Olee et al., 1999).
Gain-of-function mutations within NLRP3 have been associ-
ated with three autoinflammatory disorders characterized by
skin rashes and prolonged episodes of fever in the absence of
any apparent infection. These hereditary periodic-fever syn-
dromes are Muckle-Wells syndrome (MWS), familial cold autoin-
flammatory syndrome (FACS), and neonatal-onset multisystem
inflammatory disease (NOMID), and they are collectively referred
to as the Cryopyrin-associated periodic syndromes (CAPS)
(Agostini et al., 2004). Functional studies revealed that the
disease-associated NLRP3 mutations enhance caspase-1 acti-
vation and IL-1b secretion (Dowds et al., 2004). In addition,
decreasedNLRP3 expression and IL-1b production was recently
linked with increased susceptibility to Crohn’s disease in
humans (Villani et al., 2009). However, the role of the Nlrp3
inflammasome in colitis has not been characterized. To under-
stand the role of the Nlrp3 inflammasome in colitis, we studied
the response of Nlrp3/, Pycard/, and Casp1/ mice to
DSS-induced colitis. Our results indicated a major role for the
Nlrp3 inflammasome in protection against DSS-induced colitis
and revealed its protective function in intestinal homeostasis.
RESULTS
Nlrp3 Protects from Mortality and Morbidity after DSS
and TNBS Administration
Oral administration of DSS is directly toxic to the colonic epithe-
lium (Kitajima et al., 1999) and triggers inflammation by disrupt-
ing the compartmentalization of commensal bacteria in the gut
(Rakoff-Nahoum et al., 2004). To study the contribution of
Nlrp3 to the development of colitis, we first assessed the
mortality rate of age- and sex-matched wild-type and Nlrp3/
mice after oral administration of 4% DSS in drinking water.
Only 20% of wild-type mice died during the DSS administration
period, but a mortality rate higher than 80% was noted for the
Nlrp3/ cohort (Figure 1A). The experiment was repeated with
a lower DSS concentration (3%) to study the phenotype of
Nlrp3/ mice under milder conditions. Nlrp3/ mice suffered
from more body weight loss from day 5 on (Figure 1B). Simulta-
neously, stool consistency scores of Nlrp3/ mice became
significantly worse compared to those of DSS-fed wild-type
mice (Figure 1C). Differences in rectal bleeding were also
apparent between the two groups, withNlrp3/ mice displaying
significantly elevated scores relative to DSS-administered wild-380 Immunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc.type controls starting as early as day 2 (Figure 1D). The evalua-
tion of colon length is the parameter with the lowest variability
in the model of DSS-induced colitis (Okayasu et al., 1990).
To further assess the severity of colitis, colon length was mea-
sured in DSS-fed wild-type and Nlrp3/ mice. Colons of
Nlrp3/ mice were on average 20% shorter than those of
wild-type mice treated with DSS (Figure 1E; Figure S1A available
online).
These clinical assessments were validated by histological
examination of representative colon sections. In agreement
with previous studies (Rakoff-Nahoum et al., 2004; Takagi
et al., 2003), we observed marked histopathological changes in
hematoxylin & eosin (H&E)-stained colons of DSS-treated wild-
type mice characterized by crypt loss and infiltrating leukocytes
(Figure 1F). However, only minimal evidence of necrosis and
ulceration was evident in colons of wild-type mice. In contrast,
colonic sections of DSS-fed Nlrp3/ mice displayed severe
transmural inflammation with focal areas of extensive ulceration
and necrotic lesions. Inflammatory infiltrates filled the lamina
propria and submucosa in areas where the mucosa was intact
and often effaced the normal architecture of the tissue. Submu-
cosal edema was often marked in areas of ulceration (Figure 1F).
Semiquantitative scoring of these histological parameters con-
firmed that colitis severity in Nlrp3/ mice was significantly
higher than in wild-type mice (Figure 1G). Wild-type mice were
attributed an overall histological score of 1.625 ± 0.27, whereas
Nlrp3/ mice were assigned a score of 3.78 ± 0.15 (Figure 1G).
Consistent with the absence of disease in animals that were not
fed DSS, no signs of inflammation or tissue damage were
observed in colons of untreated wild-type and Nlrp3/ mice
(Figure S1B).
Intrarectal administration of 2,4,6-trinitrobenzenesulfonic acid
(TNBS) represents an alternative model for the induction of acute
colitis in mice through direct barrier destruction (Alex et al., 2009;
Palmen et al., 1995). To assess whether Nlrp3 also exerts
a protective role during acute TNBS-induced colitis, survival of
wild-type andNlrp3/ mice was monitored for 5 days after intra-
rectal instillation of 150 mg/kg TNBS. As observed during acute
DSS-induced colitis (Figure 1), Nlrp3/ mice were significantly
more susceptible to acute TNBS-induced mortality than wild-
type mice (Figure S1C). In addition, macroscopic scoring of
inflammation in colon confirmed that colitis severity in Nlrp3/
mice was significantly higher than in wild-type mice (Fig-
ure S1D). Collectively, these results demonstrate that Nlrp3-
dependent signaling is critical for protection against acute
DSS- and TNBS-induced mortality and morbidity.
Nlrp3 Expression in Mucosal Epithelial Cells Is Critical
for Protection against DSS-Induced Colitis
Nlrp3 is expressed in a wide range of immune cells as well as in
epithelial cells (Kummer et al., 2007). To determine the cell pop-
ulations that are critical for Nlrp3-dependent protection against
DSS-induced colitis, we generated four groups of Nlrp3 bone
marrow chimeras. In agreement with our previous results (Fig-
ure 1), Nlrp3/ mice receiving Nlrp3/ bone marrow presented
with significantly worse symptoms of colitis relative to wild-type
mice transplanted with wild-type bone marrow. Differences in
clinical disease parameters between these groups such as
body weight loss (Figure 2A), stool consistency (Figure 2B),
Figure 1. Nlrp3/ Mice Are Hypersusceptible to DSS-Induced Colitis
(A) Wild-type (n = 15) andNlrp3/ (n = 12) mice were fed a 4% DSS solution in drinking water for 5 days. Survival was monitored until day 14 after the start of DSS.
(B–G) Wild-type andNlrp3/ mice were treated with 3% DSS for 5 days, followed by regular drinking water for 2 days. (B) Body weight, (C) stool consistency, and
(D) rectal bleeding score were scored daily.
(E) Mice were sacrificed on day 7 to measure colon length.
(F) At the same time, histopathological changes in colon tissue were examined by H&E staining.
(G) Semiquantitative scoring of histopathology was performed as described in Experimental Procedures. Data represent means ± SE of a representative exper-
iment. *p < 0.05; **p < 0.01.
Immunity
Nlrp3 Inflammasome in DSS-Induced Colitisand colonic bleeding (Figure 2C) all reached statistical signifi-
cance by day 7 after DSS administration. Incidence and severity
of colitis in Nlrp3/ mice receiving wild-type bone marrow was
comparable to that of Nlrp3/ mice transplanted with Nlrp3/
bone marrow (Figures 2A–2C), suggesting that Nlrp3 expression
in nonhematopoietic cells is more important for protectionagainst colitis than Nlrp3 expression in leukocytes. Indeed,
wild-type mice transplanted with Nlrp3/ bone marrow were
less sensitive to DSS-induced colitis and presented with body
weight changes, diarrhea, and bleeding scores that were com-
parable to those of wild-type mice (Figures 2A–2C). The marked
improvement in the clinical manifestation of colitis in the latterImmunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc. 381
Figure 2. Nlrp3 Signaling in Nonhematopoetic Cells Is Critical for Protection against DSS-Induced Injury
Mice (n = 8–10/group) were treated with 3% DSS for 5 days, followed by regular drinking water for 2 days. (A) Body weight, (B) stool consistency, and (C) rectal
bleeding were scored daily. (D) Mice were sacrificed on day 7 to examine histopathological changes in colon tissue by H&E staining.
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in H&E-stained sections of the lamina propria of wild-type
mice that received wild-type or Nlrp3/ bone marrow (Fig-
ure 2D). In contrast, Nlrp3/ mice presented with extensive
crypt destruction and edema regardless of the Nlrp3 status of
the transplanted bone marrow (Figure 2D, bottom). In agree-
ment, colon homogenates of DSS-fed Nlrp3/ recipients con-
tained higher amounts of inflammatory cytokines and chemo-
kines relative to wild-type recipients (Figure S2). Overall, these
results suggest that Nlrp3 expression in local cells of the colonic
mucosa is critical for protection against DSS-induced colitis.
Inflammasome Signaling Downstream of Nlrp3 Confers
Protection against DSS-Induced Colitis
Nlrp3 recruits ASC and caspase-1 into a large protein complex
termed the ‘‘inflammasome’’ (Kanneganti et al., 2007; Lamkanfi
and Dixit, 2009). To determine whether Nlrp3 inflammasome
activation is implicated in protection against colitis, we assessed
the response of mice lacking the downstream inflammasome
components ASC and caspase-1. Similar to Nlrp3/ mice (Fig-
ure 1A),Pycard/ andCasp1/ mice were highly susceptible to
DSS-induced colitis, with nearly all Pycard/ and Casp1/
mice dying within 2 weeks after administration of 4% DSS382 Immunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc.(Figure 3A). As seen with Nlrp3/ mice, Pycard/ and
Casp1/ mice displayed significantly more body weight loss
(Figure 3B), higher stool consistency scores (Figure 3C), and
rectal bleeding (Figure 3D) when fed on a milder regimen of 3%
DSS. Moreover, the colon length of Pycard/ and Casp1/
mice was significantly reduced (Figure 3E; Figure S3A). Finally
and as observed for Nlrp3/ mice (Figure 1F), H&E-stained
colon sections of DSS-fed Pycard/ and Casp1/ mice dis-
played severe transmural inflammation with focal areas of
extensive ulceration and necrotic lesions (Figures 3F and 3G).
The role of the Nlrp3 inflammasome in protection against DSS-
induced colitis is not limited to the acute phase of disease as
shown by the fact thatNlrp3/ andCasp1/ mice also suffered
from increased body weight loss, diarrhea, and reduced colon
length during chronic disease (Figures S3B–S3F). These results
demonstrate that Nlrp3 inflammasome activation is critical for
protection against DSS-induced colitis.
IL-18 Maturation by the Nlrp3 Inflammasome Confers
Protection against DSS-Induced Colitis
The Nlrp3 inflammasome is responsible for the maturation and
secretion of the related cytokines IL-1b and IL-18 (Kanneganti
et al., 2006; Mariathasan et al., 2006; Sutterwala et al., 2006).
Figure 3. Essential Role for the Nlrp3 Inflammasome Components ASC and Caspase-1 in Protection against DSS-Induced Colitis
(A) Wild-type, Pycard/, andCasp1/ mice (n = 7–10) were fed a 4% DSS solution in drinking water for 5 days. Survival was monitored until day 14 after the start
of DSS.
(B–G) Wild-type,Pycard/, andCasp1/ mice (n = 10–14) were fed a 3% DSS solution in drinking water for 5 days, followed by regular drinking water for 2 days.
(B) Body weight, (C) stool consistency, and (D) rectal bleeding were scored daily.
(E) Mice were sacrificed on day 7 to measure colon length.
(F) Histopathological changes in colon tissue were examined by H&E staining.
(G) Semiquantitative scoring of histopathology was performed as described in Experimental Procedures.
Data represent means ± SE of a representative experiment. *p < 0.05; **p < 0.01.
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against DSS-induced colitis (Takagi et al., 2003). We therefore
determined the amounts of IL-1b and IL-18 in serum of DSS-
treated animals. IL-1b amounts in serum of wild-type, Pycard/,
andCasp1/ mice barely rose above those of untreated animals
at the three time points analyzed (days 1, 3, and 7; data not
shown). Similarly, IL-1b amounts produced by colonic tissue
from DSS-fed wild-type mice remained below 200 pg/ml,
although caspase-1-deficient cells secreted even less IL-1b (Fig-
ure S4A). Unlike IL-1b, IL-18 was highly induced in the serum of
DSS-treated wild-type mice, but not in Pycard/ and Casp1/
mice (Figure 4A). Local IL-18 production in the colon was also
induced in response to DSS treatment as evidenced by the
markedly increased IL-18 immunoreactivity (Figure 4B). In agree-
ment with an important role for IL-18 downstream of the Nlrp3
inflammasome, colons of caspase-1/ mice contained signifi-
cantly less mature IL-18 relative to DSS-fed wild-type mice
(Figure 4C). The results of the bone marrow chimera studies
(Figure 2) suggested that cells of the colonic mucosa represent
a critical site of Nlrp3 inflammasome activation during DSS-
induced colitis. To provide additional support for the colonic
mucosa as an important site for Nlrp3 inflammasome activation,
we determined the amounts of mature IL-18 produced by iso-
lated colonic epithelial cells. As in total colon extracts (Fig-
ure 4C), colonic epithelial cells isolated from DSS-fed Casp1/
mice produced markedly less mature IL-18 than those of wild-
type mice (Figure 4D). Isolated epithelial cells from colonic
epithelia stained positive for the epithelial cell marker cytokera-
tin-18 (Figure S4B). Finally, we tested the role of IL-18 in protec-
tion against DSS-induced colitis. To this end, DSS-fed Casp1/
mice received a daily injection of saline or 0.5 mg recombinant
IL-18 for 4 consecutive days. In agreement with an important
role for IL-18 downstream of the Nlrp3 inflammasome, Casp1/
mice treated with recombinant IL-18 lost significantly less body
weight when compared to those receiving PBS (Figure 4E).
Thus, Nlrp3 inflammasome signaling through IL-18 confers
protection against DSS-induced colitis.
The Nlrp3 Inflammasome Is Required for Preservation
of Epithelial Integrity after DSS Administration
IL-18 has been linked to repair and restitution of ulcerated
epithelium (Reuter and Pizarro, 2004), and colitis was previously
shown to be more severe under conditions in which epithelial
cell integrity is compromised (Rakoff-Nahoum et al., 2004).
We therefore investigated the role of the Nlrp3 inflammasome
in maintaining epithelial integrity in the gut. The intestinal barrier
permeability in Nlrp3/ and Casp1/ mice appeared normal
prior to DSS treatment (Figure 5A). However, the Nlrp3 inflamma-
some is important for regulation of gastrointestinal permeability
after DSS-induced injury because significantly more FITC-
dextran was recovered in serum of DSS-treated Nlrp3/ and
Casp1/ mice (Figure 5A).
The decreased barrier function in the absence of Nlrp3 inflam-
masome signaling could be explained by increased apoptosis of
epithelial cells and/or decreased cell proliferation. We first char-
acterized the extent of apoptosis by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) staining.
The number of TUNEL-positive cells in colonic tissue of DSS-
treated Nlrp3/ and Casp1/ mice was comparable to that384 Immunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc.of wild-type mice (data not shown), indicating that the absence
of Nlrp3 inflammasome signaling does not affect apoptosis.
50-bromo-20-deoxy-uridine (BrdU) staining was subsequently
used to determine the role of the Nlrp3 inflammasome in epi-
thelial cell proliferation. The epithelial crypts of DSS-treated
Nlrp3/ and Casp1/ mice presented with significantly less
BrdU-positive cells (Figures 5B and 5C). Untreated wild-type,
Nlrp3/, and Casp1/ mice all showed comparable amounts
of BrdU staining in colonic crypts, suggesting that the Nlrp3
inflammasome is specifically required for epithelial cell prolifera-
tion after DSS-induced injury. Therefore, activation of the Nlrp3
inflammasome induces a compensatory proliferative response
of epithelial cells in order to preserve the integrity of the epithelial
layer during DSS-induced colitis.
Increased Intestinal Barrier Permeability Results
in Commensal Overgrowth and Bacteremia
It is well established that commensal microflora in the lumen of
the colon play an essential role during intestinal inflammation
(Rembacken et al., 1999; Sutherland et al., 1991; Turunen
et al., 1998). In addition, a functional Nlrp3 inflammasome may
be required to mount a proper immune response to prevent
commensal overgrowth. We therefore asked whether the pro-
found disruption of the epithelial barrier in the colon of DSS-
fedNlrp3/ andCasp1/ mice caused commensal overgrowth
and bacteremia. To this end, mice were administered 3% DSS
for 7 days and the number of colony-forming units (CFUs) in
different tissues was determined at day 9. Significantly more
bacteria were counted in the stool, liver, colon, and mesenteric
lymph nodes (MLN) of Nlrp3/ and Casp1/ mice relative to
DSS-fed wild-type mice (Figure 6A). Increased bacteremia in
Nlrp3/ and Casp1/ mice was due to DSS treatment as
shown by the fact that untreated mice showed similar bacterial
counts in the stool and colon (Figure S5A) and their systemic
organs were devoid of bacteria (data not shown). Systemic
dissemination of bacteria and bacterial components triggers
an exuberant cytokine and chemokine inflammatory response.
To gain additional evidence of bacteremia, we measured a
variety of cytokines and chemokines in serum of DSS-fed
Nlrp3/ and Casp1/ mice. In agreement with the increased
bacterial dissemination in Nlrp3/ and Casp1/ mice, the
amounts of the chemokines eotaxin, G-CSF, KC, and MCP-1
were all significantly higher in serum of Nlrp3/ and Casp1/
mice relative to DSS-fed wild-type mice (Figures 6B–6E). In addi-
tion, serum concentrations of the proinflammatory cytokines IL-6
and TNF-a were also dramatically higher in Nlrp3/ and
Casp1/ mice when compared to wild-type mice (Figures 6F
and 6G).
We also assessed local cytokine and chemokine production
in colon tissue and found these to be consistent with those in
serum. The amounts of KC, eotaxin, G-CSF, MCP-1, and IL-6
were all higher in colons of Nlrp3/ and Casp1/ mice relative
to those of DSS-fed wild-type mice (Figure S5B). To characterize
the immune cells responsible for the increased production of
chemokines and cytokines in the colon, we examined the
expression of cell surface markers on mononuclear cells that
infiltrated the lamina propria and submucosa. Significantly
increased numbers of neutrophils and macrophages (F4/80+
cells) were observed in the colon of DSS-fed Nlrp3/ and
Figure 4. IL-18 Production by the Nlrp3 Inflammasome Is Required for Protection against DSS-Induced Colitis
(A) Wild-type, Pycard/, and Casp1/ mice were fed a 3% DSS solution in drinking water for 5 days, followed by regular drinking water for 2 days. Serum IL-18
concentrations on days 0 (n = 5/group), 3 (n = 5/group), and 7 (n = 10/group) was determined by multiplex assay.
(B–D) At day 7, colons were collected (B) and sections were stained for IL-18 (C, D), and colonic epithelial cells were isolated to determine the concentrations of
mature IL-18 by immunoblotting. Blots were reprobed for b-actin.
(E) Casp1/ mice (n = 5/group) were fed a 3% DSS solution in drinking water for 5 days, followed by regular drinking water for 2 days. One cohort simultaneously
received a daily injection of 0.5 mg recombinant IL-18, whereas the control group was injected with saline. Body weight change was monitored daily for 7 days.
Data represent means ± SE. **p < 0.01.
Immunity
Nlrp3 Inflammasome in DSS-Induced ColitisCasp1/ mice (Figure S5C, left). In contrast, CD3 (T cell) and
CD45R (B cell) staining were not significantly different in wild-
type and inflammasome-deficient mice (Figure S5C, right).These results suggest that the increased DSS-induced
morbidity and lethality in the absence of Nlrp3 inflammasome
signaling may be caused by commensal overgrowth andImmunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc. 385
Figure 5. The Nlrp3 Inflammasome Is Required for Protection against Epithelial Barrier Permeabilization and Epithelial Cell Proliferation
during DSS-Induced Colitis
(A)Wild-type,Nlrp3/, andCasp1/mice (n= 5/group)were feda 3%DSSsolution indrinkingwater for 5 days, followedby regulardrinkingwater for 2 days.Control
and DSS-fed mice were subsequently fed FITC-dextran, and FITC-dextran amounts in serum were determined 3 hr later. Data represent means ± SE; *p < 0.05.
(B) Control (left) and DSS-fed (right) mice were then injected intraperitoneally with BrdU before colon sections were prepared to visualize BrdU-positive cells.
(C) Quantification of BrdU-positive cells per crypt in colons of untreated and DSS-fed wild-type, Nlrp3/, and Casp1/ mice. 100 crypts/mouse colon of three
mice/genotype were analyzed. Data represent mean ± SE; **p < 0.001.
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Nlrp3 Inflammasome in DSS-Induced Colitisbacteremia after the breach of the intestinal barrier. An exagger-
ated immune response to these commensal bacteria may further
exacerbate disease severity. To address the role of commensal
bacteria in the increased colitis severity in inflammasome-defi-
cient mice, we examined whether clinical parameters of DSS-
induced colitis could be ameliorated with antibiotics. Nlrp3/
mice were administered a 3% DSS solution alongside a combi-
nation of the selective antibiotics metronidazole, neomycin, and
vancomycin from day 2 on. Disease severity was compared to
Nlrp3/ mice that were fed a 3% DSS solution without antibi-
otics. A dramatic improvement in the clinical scores of the anti-
biotic-treated arm was observed over Nlrp3/ mice that did
not receive antibiotics (Figures S5D–S5F). For instance, body
weight loss in the antibiotics-treated arm was around 6%,
whereas the group that was refused antibiotics presented
with a loss of more than 20%. Prominent improvements in other
clinical features including stool consistency and rectal bleeding
were also noted for antibiotics-treated Nlrp3/ mice. These
marked improvements prompted us to examine the affect of
antibiotics treatment on mortality after administration of a
4% DSS solution. As before, 80% of placebo (PBS)-treated
Nlrp3/ mice had died 2 weeks after DSS administration.
In contrast, all Nlrp3/ mice that were coadministered antibi-
otics remained alive by the end of the experiment (data not
shown). These results indicate that overgrowth of colonic micro-
flora contributed significantly to the increased DSS-induced
morbidity and lethality of Nlrp3/ mice.386 Immunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc.DISCUSSION
We show here that Nlrp3/ mice were significantly more
susceptible to DSS-induced colitis. Similar to Nlrp3/ mice,
Pycard/ and Casp1/ mice were more sensitive to colitis-
associated body weight loss, diarrhea, rectal bleeding, and
mortality during both the acute and chronic phase of disease,
indicating a key role for the Nlrp3 inflammasome in protection
against DSS-induced colitis. The role of the Nlrp3 inflammasome
in protection against colitis is not limited to the DSS-induced
model because Nlrp3/ mice also suffered from increased
body weight loss, diarrhea, and reduced colon length in the
acute TNBS-induced colitis model. Oral administration of DSS
and TNBS is directly toxic to the gut and causes crypt destruc-
tion, mucosal erosion, and ulceration. Epithelial damage induces
a localized repair response characterized by increased division
of stem cells at the base of crypts to replace damaged entero-
cytes (Radtke and Clevers, 2005). IL-18 production by the
Nlrp3 inflammasome in colonic epithelial cells was identified as
a crucial mediator of repair of the mucosal barrier and protection
against DSS-induced colitis. Indeed, IL-18 has previously been
associated to repair and restitution of ulcerated epithelium
(Reuter and Pizarro, 2004). Mature IL-18 generated by the
Nlrp3 inflammasome may subsequently bind to the IL-18R
expressed on intestinal epithelial cells and local immune cells
in the gut to exert its functions. Notably, the TLR4-MyD88
signaling axis has also been implicated in maintenance of
Figure 6. Increased Systemic Dissemination of Commensal Microflora and Cytokine Production in Nlrp3/ and Casp1/Mice during DSS-
Induced Colitis
(A) Wild-type, Nlrp3/, and Casp1/ mice (n = 8/group) were fed a 3% DSS solution in drinking water for 5 days, followed by regular drinking water for 2 days.
Bacterial counts in stool, colon, MLN, and liver of DSS-fed wild-type, Nlrp3/, and Casp1/ mice were determined at day 9.
(B–G) Serum amounts of (B) eotaxin, (C) GCSF, (D) KC, (E) MCP-1, (F) IL-6, and (G) TNF-a were measured at days 3 and 7 by multiplex assay (n = 5 mice/group).
Data represent means ± SE. *p < 0.05, **p < 0.01.
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Nlrp3 Inflammasome in DSS-Induced Colitisepithelial cell homeostasis in the gut and protection against
DSS-induced colitis (Fukata et al., 2005; Rakoff-Nahoum et al.,
2004). This suggests that MyD88 contributes to epithelial cellhomeostasis in the gut both at the level of TLR4 signaling and
downstream of the IL-18R. In addition to IL-18, the cytokines
IL-11 and IL-22 have been identified as important regulators ofImmunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc. 387
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Nlrp3 Inflammasome in DSS-Induced Colitisgastrointestinal mucosal biology (Keith et al., 1994; Zenewicz
et al., 2008). It remains to be determined whether these cyto-
kines operate in a hierarchical cascade or interact in a network
of parallel pathways to confer protection against destruction of
the mucosal barrier.
Earlier studies withCasp1/ mice and the caspase-1 inhibitor
pralnacasan suggested a detrimental rather than a protective
role for caspase-1 in DSS-induced colitis (Bauer et al., 2007;
Loher et al., 2004; Siegmund et al., 2001b). However, our obser-
vation that Casp1/ mice are more susceptible to DSS-induced
colitis is in agreement with a growing body of evidence suggest-
ing a protective role for Nlrp3 inflammasome-mediated IL-18
production during colitis. First, mice lacking the other inflamma-
some components Nlrp3 and ASC were also more susceptible to
DSS-induced colitis. Second, both Il18/ and Il18r1/ mice
were shown to display increased susceptibility to DSS-induced
colitis, which was associated with greater lethality and more
severe histopathological changes (Takagi et al., 2003). Third,
Il1r/ mice also showed increased intestinal damage and histo-
pathology during DSS-induced colitis (Lebeis et al., 2009).
Finally, several previous studies reported the development of
more severe DSS-induced colitis in mice lacking the adaptor
protein MyD88, which is required for the production of the
caspase-1 substrates IL-1b and IL-18, as well as for signaling
downstream of their respective receptors (Araki et al., 2005;
Fukata et al., 2005; Rakoff-Nahoum et al., 2004). Noteworthy,
the results from the gene-deleted mouse models described
above are sometimes in conflict with reports using (bio)chemical
approaches for neutralization of caspase-1 and IL-18. For
instance, experiments in IL-18-deficient mice suggested a bene-
ficial role for IL-18 during DSS-induced colitis (Takagi et al.,
2003), whereas IL-18 neutralization with recombinant IL-18
binding protein (Sivakumar et al., 2002) and IL-18 antibodies
suggested a detrimental role for IL-18 (Siegmund et al., 2001a).
In addition to differences in experimental design, characteristics
inherent to (bio)chemical neutralization and gene-deleted mouse
models may have contributed to the different outcomes. On the
one hand, chemical and biochemical inhibitors are most suited
for therapeutic intervention in patients, although they are unlikely
to achieve complete neutralization of the desired target and
may suffer from pleiotropic effects that could interfere with
disease outcome. On the other hand, gene-targeted deletion in
mice is a surer approach for complete removal of the protein
under study. However, the possibility that gene deletion may
trigger mild developmental defects that go unnoticed but never-
theless may influence the disease phenotype cannot be com-
pletely excluded. Thus, (bio)chemical neutralization and gene-
targeted deletion approaches each have particular advantages
and both should be considered to further our knowledge on
the mechanisms underlying human disease.
EXPERIMENTAL PROCEDURES
Mice
Nlrp3/, Pycard/, and Casp1/ mice backcrossed to C57BL/6 back-
ground for at least 10 generations have been described before (Lamkanfi
et al., 2008; Thomas et al., 2009). Mice were housed in a pathogen-free facility
and the animal studies were conducted under protocols approved by St. Jude
Children’s Research Hospital Committee on Use and Care of Animals. All mice
were male 8–10 weeks old and maintained in an SPF facility. All experiments388 Immunity 32, 379–391, March 26, 2010 ª2010 Elsevier Inc.were conducted under protocols approved by the St. Jude Children’s research
Hospital Committee on Use and Care of Animals.
Induction of DSS-Induced Colitis
For survival studies, acute colitis was induced with 4% (w/v) DSS (molecular
mass 36–40 kDa; MP Biologicals) dissolved in sterile, distilled water ad libitum
for the experimental days 1–5 followed by normal drinking water until the end
of the experiment (day 14). The DSS solutions were made fresh on day 3. For all
other experimental read-outs, DSS-induced colitis was induced by feeding
mice 3% (w/v) DSS during 5 days, followed by normal drinking water until
the end of the experiment on day 7. For bacterial count determination, mice
continued to receive a 3% DSS solution until day 7 and bacterial numbers
were determined on day 9.
Determination of Clinical Scores
Body weight, stool consistency, and the presence of occult blood were deter-
mined daily up to day 7. The baseline clinical score was determined on day 1.
Scoring for stool consistency and occult blood was done as described previ-
ously (Wirtz et al., 2007). In brief, stool scores were determined as follows: 0,
well-formed pellets; 1, semiformed stools that did not adhere to the anus; 2,
semiformed stools that adhered to the anus; 3, liquid stools that adhered to
the anus. Bleeding scores were determined as follows: 0, no blood as tested
with hemoccult (Beckman Coulter); 1, positive hemoccult; 2, blood traces in
stool visible; 3, gross rectal bleeding.
Histopathology and Immunohistochemistry
After day 7, the entire colon was excised to measure the length of the colon
and the weight of cecum. Colons were washed, fixed in 10% buffered formal-
dehyde, and embedded in paraffin. Tissue sections were stained with hema-
toxylin & eosin (H&E). Histology was scored by a pathologist in a blinded
fashion as a combination of inflammatory cell infiltration (score 0–3) and tissue
damage (score 0–3). The presence of occasional inflammatory cells in the
lamina propria was scored as 0, increased numbers of inflammatory cells in
the lamina propria was assigned score 1, confluence of inflammatory cells
extending into the submucosa was scored as 2, and transmural extension of
the infiltrate was scored as 3. For tissue damage, no mucosal damage was
scored as 0, lymphoepithelial lesions were scored as 1, surface mucosal
erosion or focal ulceration was scored as 2, and extensive mucosal damage
and extension into deeper structures of the bowel wall was scored as 3. The
combined histological score ranged from 0 (no changes) to 6 (extensive infiltra-
tion and tissue damage).
For immunohistochemistry, formalin-fixed paraffin-embedded tissues were
cut into 4 mm section and slides were stained for neutrophil, macrophage,
T cell, and B cell via the immunoperoxidase method with neutrophil, F4/80,
CD3, and CD45R/B220 antibodies, respectively. IL-18 immunostaining was
performed with a rat anti-mouse IL-18 antibody (MBL).
Recombinant IL-18
Recombinant IL-18 (MBL International) was injected intraperitoneally at
a concentration of 0.5 mg per mouse in 100 ml phosphate-buffered saline
(PBS) on days 0, 1, 2, 3, and 4.
Cytokine Measurements
Serum was collected from blood drawn by cardiac puncture at the indicated
time points. To measure the cytokine amounts in colon tissue, a part of colon
was homogenized mechanically in PBS containing 1% NP-40 and complete
protease inhibitor cocktail (Roche). Mouse cytokines and chemokines in serum
and colon homogenate were measured with Luminex (Bio-Rad) and ELISA
(R&D Systems) assays.
Immunoblotting
Tissue homogenates were lysed in lysis buffer solution (150 mM NaCl, 10 mM
Tris [pH 7.4], 5 mM EDTA, 1 mM EGTA, 0.1% Nonidet P-40) supplemented
with a protease inhibitor cocktail tablet (Roche). Samples were clarified,
denatured with SDS buffer, and boiled for 5 min. Proteins were separated by
SDS-PAGE and transferred on to nitrocellulose membranes. The membranes
were immunoblotted with primary antibodies and proteins detected with
appropriate secondary anti-rat antibody conjugated to horseradish
Immunity
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from MBL.
Isolation of Colonic Epithelial Cells
Colonic epithelial cells were isolated as described before (Greten et al., 2004).
In brief, colons were dissected, washed with PBS, and cut into small pieces.
Colon segments were incubated in HBSS supplemented with 5 mM EDTA
and 0.5 mM DTT for 30 min at 37C with gentle shaking. Cells in the superna-
tants were filtered through a 70 mm cell strainer and washed twice. Enrichment
for colonic epithelial cells was determined as the percentage of cells staining
positive for the epithelial cell-specific marker cytokeratin-18. 85%–90% of iso-
lated cells stained positive for cytokeratin-18.
Bacterial Culture
Samples of stool, colon, and liver tissue were collected in 5 ml of a 3% thiogly-
colate solution and homogenized. Different dilutions of the obtained suspen-
sions were plated on blood agar and BHI agar and incubated at 37C for
48 hr. Bacterial counts were determined by colony-forming assay.
Depletion of Commensal Bacteria
To inhibit overgrowth of commensal bacteria during DSS administration, mice
were treated with selective antibiotics: metronidazole (1g/L; Sigma) for killing
anaerobic bacteria, neomycin (1g/L; Sigma) for killing gram-negative bacteria,
and vancomycin (50 mg/Kg/day; Sigma) for inhibition of gram-positive staph-
ylococci and streptococci. Antibiotics treatment was started at day 2 after DSS
administration and continued until day 9. Metronidazole and neomycin was
added in drinking water, and vancomycin was given by oral gavage once daily.
Bone Marrow Chimeras
Bone marrow transfer was used to create Nlrp3/ chimera mice wherein the
genetic deficiency of Nlrp3 was confined to either circulating cells (Nlrp3/ >
WT chimera) or nonhematopoietic tissue (WT > Nlrp3/). In brief, bone
marrows were collected from femur and tibia of congenic WT (expressing
CD45.1 leukocyte antigen) or Nlrp3/ (expressing CD45.2 leukocyte antigen)
donor mice by flushing with HBSS. After several washing steps, cells were
resuspended in PBS at a concentration of 1 3 108/ml. 100 ml of this cell
suspension was injected retro-orbitally in irradiated donor mice. Four chimera
groups were generated WT > WT (WT cells expressing CD45.1 into WT
expressing CD45.2); WT > Nlrp3/ (WT cells expressing CD45.1 into
Nlrp3/ expressing CD45.2); Nlrp3/ > Nlrp3/ (Nlrp3 expressing CD45.2
cells into Nlrp3/ expressing CD45.2); and Nlrp3/ > WT (Nlrp3/ cells
expressing CD45.2 into WT expressing CD45.1). The use of CD45.1-express-
ing congenic mice facilitated verification of proper reconstitution in the
chimera mice. Bone marrow reconstitution was verified after 5 weeks by stain-
ing for CD45.1 and CD45.2 in blood cells with FITC-conjugated anti-CD45.1
and PE-conjugated anti-CD45.2. 7 weeks after bone marrow transfer, mice
were fed with 3% DSS for 5 days. Body weight change, stool consistency,
and rectal bleeding were monitored daily. At day 7, mice were sacrificed to
collect colon tissue for H&E staining.
In Vivo Intestinal Permeability Measurement
In vivo assay to assess epithelial barrier permeability was performed with an
FITC-labeled Dextran method as described (Furuta et al., 2001). In brief,
food and water were withdrawn and mice were gavaged with permeability
tracer FITC-dextran (Mw 4000; Sigma-Aldrich) at a concentration 60 mg/100 g
body weight. Blood was collected by heart puncture and FITC-dextran amount
in serum was measured with a fluorescence spectrophotometer setup with
emission and excitation wavelengths of, respectively, 490 nm and 520 nm.
FITC-dextran concentration was determined from standard curves generated
by serial dilution of FITC-dextran.
In Situ Intestinal Proliferation Assay
The number of proliferating cells in intestinal epithelium was detected by
immunoperoxidase staining for thymidine analougue 50-bromo-20deoxyuridine
(BrdU) as described (Rakoff-Nahoum et al., 2004). In brief, 1 mg/ml BrdU in
PBS was injected intraperitoneally. 2 hr later, colon tissue was collected and
4 cm of distal colon was fixed in 10% neutral buffered formalin and embedded
in paraffin. Immunohistochemistry was performed with an in situ BrdU stainingkit (BD Bioscience). Tissues were counterstained with hematoxylin.
The number of BrdU-positive cells per intact and well-oriented crypt was
determined.
Statistical Analysis
Data are represented as mean ± SEM. Differences in group survival and
bacteremia were analyzed with the Kaplan-Meier test with Prism5 (GraphPad
Software). In all other cases, statistical significance was determined by
Student’s t test. p < 0.05 was considered statistically significant.
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